4th case of mad cow disease found in Japan

4th case of mad cow disease found in Japan

TOKYO, Japan - Satoshi Takaya (L), chief of the Inspection and Safety Division at the Health, Labor and Welfare Ministry, speaks at a press conference at the ministry in Tokyo on May 11 about the discovery of Japan's fourth case of mad cow disease. A slaughtered 6-year-old Holstein cow in Hokkaido was found to be infected.

  • Product Code
  • ILEA001089880
  • Registered date
  • 2002/5/11 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2002 Kyodo News
  • Media size
  • 1864 × 1713 pixel
  • Resolution
  • dpi
  • Deployment size
  • 939.25(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Man who traveled from W. Africa tests negative for Ebola

    Man who traveled from W. Africa tests negative for Ebola

    TOKYO, Japan - Photo taken Oct. 28, 2014, shows the National Center for Global Health and Medicine in Tokyo's Shinjuku Ward, to which a man, who traveled from West Africa and showed elevated body temperature upon arrival at Tokyo's Haneda airport, was admitted the previous day. The Canadian journalist tested negative for the Ebola virus but will remain hospitalized and under observation for a few more days, according to the Ministry of Health, Labor and Welfare.
      Online sales of over-the-counter drugs

      Online sales of over-the-counter drugs

      TOKYO, Japan - Health, Labor and Welfare Minister Norihisa Tamura holds a press conference at the ministry in Tokyo on Nov. 6, 2013. The government said the same day that online sales of drugs moving from prescription to over-the-counter status will be banned for three years from the point of such movement in principle under new rules that could take effect next spring.
        Novartis division head Epstein

        Novartis division head Epstein

        TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, holds talks with Japanese Health, Labor and Welfare Minister Norihisa Tamura (R) at the ministry in Tokyo on Sept. 26, 2013. Tamura summoned Epstein and sharply criticized the firm for triggering a scandal involving Novartis Pharma K.K., the Japanese subsidiary of Novartis AG. The unit allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.
          Myanmar girl leaves Okayama hospital after surgery

          Myanmar girl leaves Okayama hospital after surgery

          OKAYAMA, Japan - Ni Ni Min Lwin, a 6-year-old Myanmarese girl, smiles during a press conference at the Okayama Medical Center in the city of Okayama on July 20, 2012, before leaving the hospital the same day. The girl successfully underwent surgery in May for a complex congenital urological disorder at the hospital in the western Japan city.
            Japan to tighten limits on cesium in food

            Japan to tighten limits on cesium in food

            TOKYO, Japan - The Pharmaceutical Affairs and Food Sanitation Council, an advisory council to the Health, Labor and Welfare Ministry, meets at the ministry in Tokyo on Feb. 24, 2012. The council decided to tighten limits on radioactive cesium found in food to between one-20th and a quarter of the current provisional limits, depending on food categories, from April 1.
              Fatal food poisoning at barbecue chain

              Fatal food poisoning at barbecue chain

              TOKYO, Japan - Officials of the Health, Labor and Welfare Ministry attend a press conference in Tokyo on May 5, 2011, over a string of fatal food poisoning cases believed to be caused by consuming raw meat at a ''yakiniku'' barbecue restaurant chain. The ministry asked prefectural governments to conduct emergency checks on whether restaurants serving raw meat are properly observing sanitation standards.
                49 Miyazaki stud bulls to be slaughtered

                49 Miyazaki stud bulls to be slaughtered

                TOKYO, Japan - Masahiko Yamada, senior vice minister at the Agriculture, Forestry and Fisheries Ministry, speaks during a news conference at the farm ministry in Tokyo on May 24, 2010, about the government's decision to slaughter 49 stud bulls in Miyazaki Prefecture amid the spread of foot-and-mouth disease.
                  Gov't to kill all livestock within 10 km of disease-hit areas

                  Gov't to kill all livestock within 10 km of disease-hit areas

                  TOKYO, Japan - Agriculture, Forestry and Fisheries Minister Hirotaka Akamatsu briefs reporters on measures to deal with an outbreak of foot-and-mouth disease in Miyazaki Prefecture during a press conference at the ministry in Tokyo on May 19, 2010. Akamatsu said all pigs and cows within a 10-kilometer radius of areas hit by the disease will be slaughtered to prevent the spread of the outbreak.
                    Gov't to kill all livestock within 10 km of disease-hit areas

                    Gov't to kill all livestock within 10 km of disease-hit areas

                    TOKYO, Japan - Agriculture, Forestry and Fisheries Minister Hirotaka Akamatsu briefs reporters on measures to deal with an outbreak of foot-and-mouth disease in Miyazaki Prefecture during a press conference at the ministry in Tokyo on May 19, 2010. Akamatsu said all pigs and cows within a 10-kilometer radius of areas hit by the disease will be slaughtered to prevent the spread of the outbreak.
                      Mitsubishi Tanabe Pharma ordered to suspend some operations

                      Mitsubishi Tanabe Pharma ordered to suspend some operations

                      TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (L) and Takehiko Fujii (C), president of subsidiary Bipha Corp., apologize in Tokyo on April 13, 2010, after the Health, Labor and Welfare Ministry ordered Mitsubishi Tanabe Pharma to suspend some of its pharmaceutical manufacturing and sales operations for 25 days over the alleged falsification of blood product test data. The subsidiary, which manufactured the product and falsified the data, was ordered to suspend its drug manufacturing business for 30 days.